An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Thriving Trade on Social Networks
Additionally, a robust market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.
Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.
Online Marketplace Operations
Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.
After moments of entering one community, a seller posted contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.
Item Details and Costs
Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.
